Partnership funds vital research into childhood leukaemia
Children’s Cancer and Leukaemia Group (CCLG) has partnered with the Harley Staples Cancer Trust (HSCT) to fund crucial new research into why leukaemia relapses.
Children’s Cancer and Leukaemia Group (CCLG) has partnered with the Harley Staples Cancer Trust (HSCT) to fund crucial new research into why leukaemia relapses.
A recent public survey undertaken by Children’s Cancer and Leukaemia Group (CCLG) has found that nearly 60% of childhood cancer survivors are faced with a range of health challenges, with the biggest impact on emotional and mental health.
Children’s Cancer and Leukaemia Group (CCLG) is deeply saddened to hear one of its founder members and pioneers in paediatric oncology, Professor Jillian Mann, MBE, has passed away, aged 84.
The launch of the final report of the Children’s Cancer Priority Setting Partnership (PSP) was marked recently with a special event in London (28 June).
Two men have raised almost £3,000 for Children’s Cancer and Leukaemia Group (CCLG) by cycling the entire length of Great Britain in just five days.
For many parents, reaching the end of treatment can bring mixed emotions. This is the moment you have waited for since hearing your child’s diagnosis.
Children’s Cancer and Leukaemia Group (CCLG) is delighted to announce two new research projects that will help further understanding of childhood acute lymphoblastic leukaemia (ALL).
Gemma Hebbron scaled the UK’s tallest sculpture, the 80 metre-high ArcelorMittal Orbit in London, for Thomas Fight TALL, a Special Named Fund at Children’s Cancer and Leukaemia Group (CCLG) that raises money for research into childhood leukaemias.
Matt Redwood, from Wiveliscombe, took on the first of an endurance-testing trilogy in Luxembourg last month in support of Jack’s Journey, which raises money for research into Langerhans cell histiocytosis (LCH), a rare cancer that affects around 50 children a year in the UK.
Children’s Cancer and Leukaemia Group (CCLG) is proud to announce a new research project which aims to improve treatment for children with a rare variant of leukaemia.